Literature DB >> 9457397

Renal cell carcinoma and interleukin-2: what are the endpoints?

R A Figlin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9457397

Source DB:  PubMed          Journal:  Cancer J Sci Am        ISSN： 1081-4442


× No keyword cloud information.
  1 in total

Review 1.  The current role of immunotherapy for renal cell carcinoma in the era of targeted therapeutics.

Authors:  Michael K K Wong
Journal:  Curr Oncol Rep       Date:  2008-05       Impact factor: 5.075
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.